Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP3-461F17.3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | AHCY | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | KIFC3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | DUSP7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SCAF1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | AATK-AS1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | KBTBD12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | EIF4EBP2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | RP11-219A15.1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SMG9 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |